Australian Firm Genetic Signatures Raises $25M; Eyes US, European Markets

Nov 27, 2019

|

NEW YORK – Australian molecular diagnostics firm Genetic Signatures has raised $25 million, it said on Wednesday.

The investors in the financing were Regal Funds Management, Perennial Value Management, Asia Union Investments, and Karst Peak Capital, a spokesman for Genetic Signatures said. Asia Union Investments is the family office of Genetic Signaures majority holder and Cofounder Chris Abbott.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Letters Urge Review of Decision to End Coronavirus Grant

Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.

Confidence Boost

A new Pew Research Center poll finds confidence in medical researchers has grown among US adults since the start of the coronavirus pandemic.

US Concerns Over BGI Testing in Middle East

Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.

Science Studies Describe Machine Learning Algorithm to Speed Mendelian Diagnoses, Safe Drug Response Gene, More

In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.

Menu

Australian Firm Genetic Signatures Raises $25M; Eyes US, European Markets

To read the full story....

Breaking News

People in the News: Tony Serafini-Lamanna, Martin Chavez, Sun Kim, Oved Amitay, More

In Brief This Week: ArcherDX, Sherlock Biosciences, Caris Life Sciences, and More

New Products Posted to GenomeWeb: Aalto Bio Reagents, Thermo Fisher, Oxford Immunotec, More

BioCore, SolGent, Seasun Get FDA Emergency Use Authorizations for Coronavirus Tests

P23 Labs Receives FDA Emergency Use Authorization for SARS-CoV-2 Test

Northern, Southern Italian Populations Began to Diverge Genetically Thousands of Years Ago

The Scan

Letters Urge Review of Decision to End Coronavirus Grant

Confidence Boost

US Concerns Over BGI Testing in Middle East

Science Studies Describe Machine Learning Algorithm to Speed Mendelian Diagnoses, Safe Drug Response Gene, More

What's Popular?

Roche Acquires Sequencing Company Stratos Genomics

BioCore, SolGent, Seasun Get FDA Emergency Use Authorizations for Coronavirus Tests

Agilent Posts Flat Q2 2020 Revenue Growth

Mammoth Biosciences, GSK Developing CRISPR-Based SARS-CoV-2 Diagnostic for Home Testing

Volpara Solutions, Ambry Genetics Form Breast Cancer Management Alliance

Sponsorships